메뉴 건너뛰기




Volumn 27, Issue 8, 2013, Pages 1754-1757

A TC classification-based predictor for multiple myeloma using multiplexed real-time quantitative PCR

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CYCLIN D1; CYCLIN D2; FIBROBLAST GROWTH FACTOR RECEPTOR 3; TRANSCRIPTION FACTOR MAFB;

EID: 84881482012     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2013.12     Document Type: Letter
Times cited : (34)

References (13)
  • 1
    • 27244445489 scopus 로고    scopus 로고
    • Molecular pathogenesis and a consequent classification of multiple myeloma
    • DOI 10.1200/JCO.2005.05.021
    • Bergsagel PL, Kuehl WM. Molecular pathogenesis and a consequent classification of multiple myeloma. J Clin Oncol 2005; 23: 6333-6338. (Pubitemid 46218843)
    • (2005) Journal of Clinical Oncology , vol.23 , Issue.26 , pp. 6333-6338
    • Bergsagel, P.L.1    Kuehl, W.M.2
  • 2
    • 74049162897 scopus 로고    scopus 로고
    • International Myeloma Working Group molecular classification of multiple myeloma: Spotlight review
    • Fonseca R, Bergsagel PL, Drach J, Shaughnessy J, Gutierrez N, Stewart AK et al. International Myeloma Working Group molecular classification of multiple myeloma: spotlight review. Leukemia 2009; 23: 2210-2221.
    • (2009) Leukemia , vol.23 , pp. 2210-2221
    • Fonseca, R.1    Bergsagel, P.L.2    Drach, J.3    Shaughnessy, J.4    Gutierrez, N.5    Stewart, A.K.6
  • 3
    • 84856706335 scopus 로고    scopus 로고
    • A novel prognostic model in myeloma based on co-segregating adverse FISH lesions and the ISS: Analysis of patients treated in the MRC Myeloma IX trial
    • Boyd KD, Ross FM, Chiecchio L, Dagrada GP, Konn ZJ, Tapper WJ et al. A novel prognostic model in myeloma based on co-segregating adverse FISH lesions and the ISS: analysis of patients treated in the MRC Myeloma IX trial. Leukemia 2012; 26: 349-355.
    • (2012) Leukemia , vol.26 , pp. 349-355
    • Boyd, K.D.1    Ross, F.M.2    Chiecchio, L.3    Dagrada, G.P.4    Konn, Z.J.5    Tapper, W.J.6
  • 4
  • 7
    • 79952123613 scopus 로고    scopus 로고
    • A mechanistic rationale for MEK inhibitor therapy in myeloma based on blockade of MAF oncogene expression
    • Annunziata CM, Hernandez L, Davis RE, Zingone A, Lamy L, Lam LT et al. A mechanistic rationale for MEK inhibitor therapy in myeloma based on blockade of MAF oncogene expression. Blood 2011; 117: 2396-2404.
    • (2011) Blood , vol.117 , pp. 2396-2404
    • Annunziata, C.M.1    Hernandez, L.2    Davis, R.E.3    Zingone, A.4    Lamy, L.5    Lam, L.T.6
  • 8
    • 22044440425 scopus 로고    scopus 로고
    • Cyclin D dysregulation: An early and unifying pathogenic event in multiple myeloma
    • DOI 10.1182/blood-2005-01-0034
    • Bergsagel PL, Kuehl WM, Zhan F, Sawyer J, Barlogie B, Shaughnessy Jr J. Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma. Blood 2005; 106: 296-303. (Pubitemid 40967205)
    • (2005) Blood , vol.106 , Issue.1 , pp. 296-303
    • Bergsagel, P.L.1    Kuehl, W.M.2    Zhan, F.3    Sawyer, J.4    Barlogie, B.5    Shaughnessy Jr., J.6
  • 9
    • 78650174738 scopus 로고    scopus 로고
    • First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): A randomised controlled trial
    • Morgan GJ, Davies FE, Gregory WM, Cocks K, Bell SE, Szubert AJ et al. First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial. Lancet 2010; 376: 1989-1999.
    • (2010) Lancet , vol.376 , pp. 1989-1999
    • Morgan, G.J.1    Davies, F.E.2    Gregory, W.M.3    Cocks, K.4    Bell, S.E.5    Szubert, A.J.6
  • 10
    • 0037441747 scopus 로고    scopus 로고
    • In multiple myeloma, t(4;14)(p16;q32) is an adverse prognostic factor irrespective of FGFR3 expression
    • DOI 10.1182/blood-2002-06-1675
    • Keats JJ, Reiman T, Maxwell CA, Taylor BJ, Larratt LM, Mant MJ et al. In multiple myeloma, t(4;14)(p16;q32) is an adverse prognostic factor irrespective of FGFR3 expression. Blood 2003; 101: 1520-1529. (Pubitemid 36182529)
    • (2003) Blood , vol.101 , Issue.4 , pp. 1520-1529
    • Keats, J.J.1    Reiman, T.2    Maxwell, C.A.3    Taylor, B.J.4    Larratt, L.M.5    Mant, M.J.6    Belch, A.R.7    Pilarski, L.M.8
  • 12
    • 34249652414 scopus 로고    scopus 로고
    • Kip1-dependent and -independent mechanisms
    • DOI 10.1182/blood-2006-07-038703
    • Zhan F, Colla S, Wu X, Chen B, Stewart JP, Kuehl WM et al. CKS1B, overexpressed in aggressive disease, regulates multiple myeloma growth and survival through SKP2-and p27Kip1-dependent and-independent mechanisms. Blood 2007; 109: 4995-5001. (Pubitemid 46827799)
    • (2007) Blood , vol.109 , Issue.11 , pp. 4995-5001
    • Zhan, F.1    Colla, S.2    Wu, X.3    Chen, B.4    Stewart, J.P.5    Kuehl, W.M.6    Barlogie, B.7    Shaughnessy Jr., J.D.8
  • 13
    • 84861488903 scopus 로고    scopus 로고
    • Prediction of cytogenetic abnormalities with gene expression profiles
    • Zhou Y, Zhang Q, Stephens O, Heuck CJ, Tian E, Sawyer JR et al. Prediction of cytogenetic abnormalities with gene expression profiles. Blood 2012; 119: e148-e150.
    • (2012) Blood , vol.119
    • Zhou, Y.1    Zhang, Q.2    Stephens, O.3    Heuck, C.J.4    Tian, E.5    Sawyer, J.R.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.